NUVA
NuVasive Inc
Price:  
39.75 
USD
Volume:  
31,368,200.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NuVasive EV/EBITDA

21.7%
Upside

As of 2025-12-19, the EV/EBITDA ratio of NuVasive Inc (NUVA) is 15.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NuVasive's latest enterprise value is 2,800.56 mil USD. NuVasive's TTM EBITDA according to its financial statements is 183.33 mil USD. Dividing these 2 quantities gives us the above NuVasive EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.9x - 16.1x 15.0x
Forward P/E multiples 17.0x - 24.6x 19.3x
Fair Price 34.87 - 77.55 48.37
Upside -12.3% - 95.1% 21.7%
39.75 USD
Stock Price
48.37 USD
Fair Price

NuVasive EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA